Once kidney disease is suspected or confirmed, these markers help with staging and monitoring rather than serving as a scoreboard. IRIS staging commonly uses creatinine and considers SDMA as supportive information, while other data—urine protein, blood pressure, phosphorus—shape risk and next steps. In feline chronic kidney disease, SDMA, urea, creatinine, and phosphorus-related markers can move together as disease progresses, which is why follow-up panels often include more than the “big three” (Grelová, 2022). The goal is to understand durability and rebound capacity, not to chase a perfect number.
At home, monitoring becomes about comfort and function: steady appetite, stable weight, and predictable litter box habits. Owners reading about chronic kidney disease in cats or dogs may notice overlap with “drinking a lot of water” pages, because thirst changes are often what families see first. Those observations, paired with scheduled labs, help the veterinarian adjust the plan before a crisis develops.